These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 35390784)

  • 1. Identification of Survival-Related Metabolic Genes and a Novel Gene Signature Predicting the Overall Survival for Patients with Uveal Melanoma.
    Guo X; Yu X; Li F; Xia Q; Ren H; Chen Z; Xing Y
    Ophthalmic Res; 2022; 65(5):516-528. PubMed ID: 35390784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Comprehensive Prognostic and Immunological Analysis of a Six-Gene Signature Associated With Glycolysis and Immune Response in Uveal Melanoma.
    Liu J; Lu J; Li W
    Front Immunol; 2021; 12():738068. PubMed ID: 34630418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An autophagy-related prognostic signature associated with immune microenvironment features of uveal melanoma.
    Zheng Z; Zhang L; Tu Z; Deng Y; Yin X
    Biosci Rep; 2021 Mar; 41(3):. PubMed ID: 33682883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction and validation of a novel prognostic signature for uveal melanoma based on five metabolism-related genes.
    Zhao H; Chen Y; Shen P; Gong L
    Math Biosci Eng; 2021 Sep; 18(6):8045-8063. PubMed ID: 34814288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and validation of a CCL18-related signature for prediction of overall survival in patients with uveal melanoma.
    Yang B; Fan Y; Chen M; Tang L; Tang X; Li H; Gu A; Liang R; Wu Y
    Exp Eye Res; 2023 May; 230():109448. PubMed ID: 36967081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High EIF4E2 expression is an independent prognostic risk factor for poor overall survival and recurrence-free survival in uveal melanoma.
    Yang B; Gu A; Wu Y
    Exp Eye Res; 2021 May; 206():108558. PubMed ID: 33785306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrative analysis identifies key genes related to metastasis and a robust gene-based prognostic signature in uveal melanoma.
    Lei S; Zhang Y
    BMC Med Genomics; 2022 Mar; 15(1):61. PubMed ID: 35300699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and Validation of a Novel Ferroptosis-Related LncRNA Signature for Predicting Prognosis and the Immune Landscape Features in Uveal Melanoma.
    Ma X; Yu S; Zhao B; Bai W; Cui Y; Ni J; Lyu Q; Zhao J
    Front Immunol; 2022; 13():922315. PubMed ID: 35774794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenic profiling of metastatic uveal melanoma discerns a potential signature related to prognosis.
    Wang J; Liu M; Sun J; Zhang Z
    J Cancer Res Clin Oncol; 2024 Jan; 150(1):23. PubMed ID: 38246894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction and validation of a pyroptosis-related gene signature associated with the tumor microenvironment in uveal melanoma.
    Zhang F; Deng Y; Wang D; Wang S
    Sci Rep; 2022 Jan; 12(1):1640. PubMed ID: 35102195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of survival-related genes and a novel gene-based prognostic signature involving the tumor microenvironment of uveal melanoma.
    Lei S; Zhang Y
    Int Immunopharmacol; 2021 Jul; 96():107816. PubMed ID: 34162166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Novel Ferroptosis-Associated Gene Signature to Predict Prognosis in Patients with Uveal Melanoma.
    Luo H; Ma C
    Diagnostics (Basel); 2021 Feb; 11(2):. PubMed ID: 33540700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and validation of immunogenic cell death-related signature for predicting the prognosis and immune landscape of uveal melanoma.
    Hu Y; Cai J; Ye M; Mou Q; Zhao B; Sun Q; Lou X; Zhang H; Zhao Y
    Front Immunol; 2022; 13():1037128. PubMed ID: 36466923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and validation of a costimulatory molecule-related signature to predict the prognosis for uveal melanoma patients.
    Zhao M; Yu Y; Song Z
    Sci Rep; 2024 Apr; 14(1):9146. PubMed ID: 38644411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Novel 8-Gene Prognostic Signature for Survival Prediction of Uveal Melanoma.
    Tang Z; Cai K
    Anal Cell Pathol (Amst); 2021; 2021():6693219. PubMed ID: 34434692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Novel Glycolysis-Related Signature for Predicting the Prognosis and Immune Infiltration of Uveal Melanoma.
    Guo X; Yu X; Zhang Y; Luo H; Huang R; Zeng Y; Duan C; Chen C
    Ophthalmic Res; 2023; 66(1):692-705. PubMed ID: 36858025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alternative Splicing Events as Indicators for the Prognosis of Uveal Melanoma.
    Wan Q; Sang X; Jin L; Wang Z
    Genes (Basel); 2020 Feb; 11(2):. PubMed ID: 32098099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Construction of oxidative phosphorylation-related prognostic risk score model in uveal melanoma.
    Zhan Z; Lin K; Wang T
    BMC Ophthalmol; 2024 May; 24(1):204. PubMed ID: 38698303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Six-gene-based prognostic model predicts overall survival in patients with uveal melanoma.
    Wan Q; Tang J; Lu J; Jin L; Su Y; Wang S; Cheng Y; Liu Y; Li C; Wang Z
    Cancer Biomark; 2020; 27(3):343-356. PubMed ID: 31903983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction of immune-related risk signature for uveal melanoma.
    Zhang Z; Ni Y; Chen G; Wei Y; Peng M; Zhang S
    Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):912-919. PubMed ID: 32496920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.